# Eleison Pharmaceuticals Inc — Form D

Eleison Pharmaceuticals Inc of PRINCETON, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2022-09-14. The offering totals $1.0M, of which $980K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2022-09-14
- Form: D
- Accession: 0001682220-22-000001
- Industry: Pharmaceuticals
- Exemptions: 06b, 4a5
- Total offering: $1.0M
- Amount sold: $980K
- Remaining: $20K
- Minimum investment: $25K
- Investors: 20
- Date of first sale: 2022-04-28
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-458772

## Issuer

- Name: Eleison Pharmaceuticals Inc
- CIK: 0001880047
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 100 OVERLOOK CENTER, 2ND FLOOR, PRINCETON, NJ, 08540
- Phone: 215-554-3530

## Officers, directors & promoters (10)

| Name | Role | Location |
| --- | --- | --- |
| Joel Allen Morganroth | Director | Princeton, NJ |
| Michael J Otto | Director | Princeton, NJ |
| Frank J Seidman | Director | Princeton, NJ |
| Edwin J Thomas | Director | Princeton, NJ |
| Bryan R Wood | Director | Princeton, NJ |
| Matthew Allen Cromie | Executive Officer | Princeton, NJ |
| William Vincent Fricker | Executive Officer | Princeton, NJ |
| Michael E Lusty | Executive Officer | Princeton, NJ |
| Patrick E Maguire | Executive Officer | Princeton, NJ |
| Edwin J Thomas | Executive Officer | Princeton, NJ |

## More

- [CIK 1880047 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1880047&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001682220-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.